JP5427422B2 - Oil-in-water emulsion composition - Google Patents
Oil-in-water emulsion composition Download PDFInfo
- Publication number
- JP5427422B2 JP5427422B2 JP2009014513A JP2009014513A JP5427422B2 JP 5427422 B2 JP5427422 B2 JP 5427422B2 JP 2009014513 A JP2009014513 A JP 2009014513A JP 2009014513 A JP2009014513 A JP 2009014513A JP 5427422 B2 JP5427422 B2 JP 5427422B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- salt
- emulsion composition
- water emulsion
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 63
- 239000007764 o/w emulsion Substances 0.000 title claims description 41
- 150000003839 salts Chemical class 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 18
- 235000008160 pyridoxine Nutrition 0.000 claims description 9
- 239000011677 pyridoxine Substances 0.000 claims description 9
- 229940011671 vitamin b6 Drugs 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- 206010012444 Dermatitis diaper Diseases 0.000 claims description 6
- 208000003105 Diaper Rash Diseases 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 239000003899 bactericide agent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000002736 nonionic surfactant Substances 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 4
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical group CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 3
- 239000004264 Petrolatum Substances 0.000 claims description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940066842 petrolatum Drugs 0.000 claims description 3
- 235000019271 petrolatum Nutrition 0.000 claims description 3
- 229940057995 liquid paraffin Drugs 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 238000004945 emulsification Methods 0.000 claims 1
- -1 alkylbenzene sulfonate Chemical class 0.000 description 23
- 235000002639 sodium chloride Nutrition 0.000 description 22
- 239000003945 anionic surfactant Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 238000005187 foaming Methods 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 5
- GFOBSZSXQKGNMN-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O GFOBSZSXQKGNMN-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000002202 Polyethylene glycol Chemical class 0.000 description 3
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229920001223 polyethylene glycol Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N KU0063794 Natural products CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- UKSFMDODPANKJI-UHFFFAOYSA-M sodium;2-[methyl(octadecanoyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O UKSFMDODPANKJI-UHFFFAOYSA-M 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- DABQDIXIAXPQFG-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]ethanesulfonic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O DABQDIXIAXPQFG-UHFFFAOYSA-N 0.000 description 1
- ZCOLQXXFCPFSNU-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O ZCOLQXXFCPFSNU-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OTTPFCJTQXRWHO-UHFFFAOYSA-N 3-(2,3-dichloroanilino)cyclohex-2-en-1-one Chemical compound ClC1=CC=CC(NC=2CCCC(=O)C=2)=C1Cl OTTPFCJTQXRWHO-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- MYGVPKMVGSXPCQ-JEDNCBNOSA-N Methylmethionine sulfonium salt Chemical compound [Cl-].C[S+](C)CC[C@H](N)C(O)=O MYGVPKMVGSXPCQ-JEDNCBNOSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- KCFRUUYAXCDZNZ-UHFFFAOYSA-N N-dodecanoyltaurine Chemical compound CCCCCCCCCCCC(=O)NCCS(O)(=O)=O KCFRUUYAXCDZNZ-UHFFFAOYSA-N 0.000 description 1
- XPZFMHCHEWYIGE-UHFFFAOYSA-N N-tetradecanoyltaurine Chemical compound CCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O XPZFMHCHEWYIGE-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 150000003227 pyridoxines Chemical class 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- KKDONKAYVYTWGY-UHFFFAOYSA-M sodium;2-(methylamino)ethanesulfonate Chemical compound [Na+].CNCCS([O-])(=O)=O KKDONKAYVYTWGY-UHFFFAOYSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003170 water-soluble synthetic polymer Polymers 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、水中油型乳化組成物に関する。 The present invention relates to an oil-in-water emulsion composition.
水中油型乳化組成物は、陰イオン界面活性剤を配合することで安定化することが知られている。水中油型乳化組成物中の陰イオン界面活性剤は、疎水性分散液滴の負の電荷を高め、その反発力を強めることによって液滴の合一を阻止する。 It is known that an oil-in-water emulsion composition is stabilized by incorporating an anionic surfactant. The anionic surfactant in the oil-in-water emulsion composition increases the negative charge of the hydrophobic dispersed droplets and prevents the droplets from coalescing by increasing their repulsive force.
しかし、水中油型乳化組成物が酸性の場合には、陰イオン界面活性剤を配合しても、分離やクリーミングが起こるなど、安定な乳化組成物が得られない問題があった。特に粘度が1000mPa・s以下である低粘度の乳化組成物で顕著であった。 However, when the oil-in-water emulsion composition is acidic, there is a problem that even if an anionic surfactant is added, a stable emulsion composition cannot be obtained, such as separation and creaming. This was particularly noticeable in low-viscosity emulsion compositions having a viscosity of 1000 mPa · s or less.
特許文献1には、化粧料に添加しうる陰イオン界面活性剤として、アルキルベンゼンスルホン酸塩、アルキル又はアルケニルエーテル硫酸塩、アルキル又はアルケニル硫酸塩、オレフィンスルホン酸塩、アルカンスルホン酸塩、不飽和脂肪酸塩、アルキル又はアルケニルエーテルカルボン酸塩、α−スルホ脂肪酸塩又はエステル、N−アシルアミノ酸型界面活性剤、リン酸モノ又はジエステル型界面活性剤が例示され、実施例1に界面活性剤として、非イオン界面活性剤であるポリオキシエチレン(10)硬化ヒマシ油、モノステアリン酸ソルビタン、陰イオン界面活性剤であるステアロイルメチルタウリンナトリウム、ポリオキシエチレンラウリルエーテルリン酸ナトリウムを配合した水中油型クリームが記載されているが、水中油型クリームの粘度は通常5〜100Pa・s程度である。 In Patent Document 1, as an anionic surfactant that can be added to cosmetics, alkylbenzene sulfonate, alkyl or alkenyl ether sulfate, alkyl or alkenyl sulfate, olefin sulfonate, alkane sulfonate, unsaturated fatty acid Examples include salts, alkyl or alkenyl ether carboxylates, α-sulfo fatty acid salts or esters, N-acyl amino acid type surfactants, phosphate mono- or diester type surfactants. An oil-in-water cream containing polyoxyethylene (10) hydrogenated castor oil as an ionic surfactant, sorbitan monostearate, sodium stearoylmethyl taurate as an anionic surfactant, and sodium polyoxyethylene lauryl ether phosphate is described. Although it is an oil-in-water chestnut The viscosity of the beam is usually about 5~100Pa · s.
特許文献2には、界面活性剤として、水素添加リン脂質、モノステアリン酸ポリエチレングリコール(100モル)及びステアロイルメチルタウリンナトリウムを配合した乳液タイプの水中油型乳化皮膚化粧料が記載されているが、当該製剤の粘度は2900Pa・sであり、その組成から、製剤のpHは5以下にはなっていないと考えられる。 Patent Document 2 describes an emulsion-type oil-in-water emulsified skin cosmetic in which hydrogenated phospholipid, polyethylene glycol monostearate (100 mol) and sodium stearoylmethyl taurate are blended as surfactants. The viscosity of the preparation is 2900 Pa · s, and from the composition, the pH of the preparation is considered not to be 5 or less.
本発明は、pHが5以下であり、かつ粘度が1〜1000mPa・s、特に1〜500mPa・sである水中油型乳化組成物を安定化させることを課題とする。 An object of the present invention is to stabilize an oil-in-water emulsion composition having a pH of 5 or less and a viscosity of 1 to 1000 mPa · s, particularly 1 to 500 mPa · s.
本発明の要旨は、以下のとおりである。
(1)N−アシルタウリン塩を0.1〜2質量%含有し、pHが5以下であり、かつ粘度が1〜1000mPa・sである水中油型乳化組成物。
(2)更にピリドキシン又はその塩を含有する前記(1)に記載の水中油型乳化組成物。
(3)おむつかぶれ改善用である前記(2)に記載の水中油型乳化組成物。
(4)更にワセリン及び/又は流動パラフィンを含有する前記(1)〜(3)のいずれかに記載の水中油型乳化組成物。
(5)N−アシルタウリン塩がN−アルキル置換及びN−アルキル非置換のN−アシルタウリン塩から選ばれる少なくとも1種である前記(1)〜(4)のいずれかに記載の水中油型乳化組成物。
(6)pHが5以下であり、かつ粘度が1〜1000mPa・sである水中油型乳化組成物において、N−アシルタウリン塩を0.1〜2質量%配合して安定化させることを特徴とする水中油型乳化組成物の安定化方法。
The gist of the present invention is as follows.
(1) An oil-in-water emulsion composition containing 0.1 to 2% by mass of an N-acyl taurine salt, having a pH of 5 or less and a viscosity of 1 to 1000 mPa · s.
(2) The oil-in-water emulsion composition according to (1), further containing pyridoxine or a salt thereof.
(3) The oil-in-water emulsion composition according to (2), which is used for improving diaper rash.
(4) The oil-in-water emulsion composition according to any one of (1) to (3), further containing petrolatum and / or liquid paraffin.
(5) The oil-in-water type according to any one of (1) to (4), wherein the N-acyl taurine salt is at least one selected from N-alkyl substituted and N-alkyl unsubstituted N-acyl taurine salts. Emulsified composition.
(6) In an oil-in-water emulsion composition having a pH of 5 or less and a viscosity of 1 to 1000 mPa · s, 0.1 to 2% by mass of N-acyl taurine salt is blended and stabilized. A method for stabilizing an oil-in-water emulsion composition.
本発明によれば、pHが5以下であり、粘度が1〜1000mPa・s、特に1〜500mPa・sである水中油型乳化組成物を安定化させることができる。 According to the present invention, an oil-in-water emulsion composition having a pH of 5 or less and a viscosity of 1 to 1000 mPa · s, particularly 1 to 500 mPa · s can be stabilized.
以下、本発明を詳細に説明する。
本発明の水中油型乳化組成物は、特定の陰イオン界面活性剤であるN−アシルタウリン塩を含有する。
Hereinafter, the present invention will be described in detail.
The oil-in-water emulsion composition of the present invention contains an N-acyl taurine salt which is a specific anionic surfactant.
本発明に用いるN−アシルタウリン塩は、タウリン塩又はN−モノアルキルタウリン塩の窒素原子がアシル基で置換され、かつ界面活性作用を有するものであれば、特に制限はない。 The N-acyl taurine salt used in the present invention is not particularly limited as long as the nitrogen atom of the taurine salt or N-monoalkyl taurine salt is substituted with an acyl group and has a surface activity.
前記N−アシルタウリン塩におけるアシル基としては、当該N−アシルタウリン塩が界面活性作用を有する限り、特に制限はなく、好ましくは炭素数8〜22の飽和又は不飽和の脂肪酸由来のアシル基、例えばラウロイル(C12)、ミリストイル(C14)、パルミトイル(C16)、ステアロイル(C18)、オレオイル(C18:1)、ココイル(ヤシ油脂肪酸アシル)が挙げられる。前記N−アシル−N−アルキルタウリン塩におけるアルキル基としては、特に制限はなく、好ましくは炭素数1〜3の低級アルキル基、例えばメチル基が挙げられる。 The acyl group in the N-acyl taurine salt is not particularly limited as long as the N-acyl taurine salt has a surface activity, and preferably an acyl group derived from a saturated or unsaturated fatty acid having 8 to 22 carbon atoms, Examples include lauroyl (C 12 ), myristoyl (C 14 ), palmitoyl (C 16 ), stearoyl (C 18 ), oleoyl (C 18: 1 ), and cocoyl (coconut oil fatty acid acyl). There is no restriction | limiting in particular as an alkyl group in the said N-acyl-N-alkyl taurine salt, Preferably a C1-C3 lower alkyl group, for example, a methyl group, is mentioned.
N−アシルタウリンの塩としては、例えばナトリウム塩、カリウム塩、アンモニウム塩、トリエタノールアミン塩、ジエタノールアミン塩、モノエタノールアミン塩、アルギニン塩、リジン塩、ヒスチジン塩、オルチニン塩、オキシリジン塩が挙げられる。 Examples of the salt of N-acyl taurine include sodium salt, potassium salt, ammonium salt, triethanolamine salt, diethanolamine salt, monoethanolamine salt, arginine salt, lysine salt, histidine salt, ortinine salt, and oxylysine salt.
本発明に用いるN−アシルタウリン塩としては、例えばN−ラウロイルタウリンナトリウム、N−ミリストイルタウリンナトリウム、N−ココイルタウリンナトリウム、N−オレオイルタウリン酸ナトリウム、N−パルミトイルタウリン酸ナトリウム、N−ラウロイル−N−メチルタウリンナトリウム、N−ミリストイル−N−メチルタウリンナトリウム、N−ココイル−N−メチルタウリンナトリウム等が挙げられる。これらのN−アシルタウリン塩は、単独又は2種以上を混合して用いることができる。 Examples of the N-acyl taurine salt used in the present invention include N-lauroyl taurine sodium, N-myristoyl taurine sodium, N-cocoyl taurine sodium, N-oleoyl taurate sodium, N-palmitoyl taurate sodium, N-lauroyl- Examples include sodium N-methyltaurine, sodium N-myristoyl-N-methyltaurine, sodium N-cocoyl-N-methyltaurine, and the like. These N-acyl taurine salts can be used alone or in admixture of two or more.
本発明の水中油型乳化組成物におけるN−アシルタウリン塩の配合量は0.1〜2質量%であることが必要である。N−アシルタウリン塩の配合量が前記下限未満であると、水中油型乳化組成物を安定化させる効果が不十分であり、前記上限を超えると、溶かして用いる場合に泡立ちを生じたり、肌に直接塗布する場合には皮膚刺激性が高くなるため、好ましくない。 The compounding quantity of the N-acyl taurine salt in the oil-in-water emulsion composition of this invention needs to be 0.1-2 mass%. When the blending amount of the N-acyl taurine salt is less than the lower limit, the effect of stabilizing the oil-in-water emulsion composition is insufficient, and when the upper limit is exceeded, foaming may occur when dissolved and used. When directly applied to the skin, the skin irritation is increased, which is not preferable.
水中油型乳化組成物は、酸性でかつ低粘度の場合に、陰イオン界面活性剤を配合しても安定化が困難であることから、本発明は、pHが5以下であり、かつ粘度が1〜1000mPa・s、特に1〜500mPa・sである水中油型乳化組成物を対象とする。 When the oil-in-water emulsion composition is acidic and has a low viscosity, it is difficult to stabilize even if an anionic surfactant is added. Therefore, the present invention has a pH of 5 or less and a viscosity of The target is oil-in-water emulsion compositions having a viscosity of 1 to 1000 mPa · s, particularly 1 to 500 mPa · s.
本発明の水中油型乳化組成物は、ピリドキシン(ビタミンB6)又はその塩を配合することにより、おむつかぶれの改善効果を発揮する。ここで用いるピリドキシンの塩としては、酸付加塩、例えば塩酸塩、硫酸塩、リン酸塩等の無機酸塩、酢酸塩、マレイン酸塩、フマル酸塩、酒石酸塩、クエン酸塩、乳酸塩等の有機酸塩が挙げられる。 The oil-in-water emulsion composition of the present invention exhibits an effect of improving diaper rash by adding pyridoxine (vitamin B 6 ) or a salt thereof. The pyridoxine salt used here is an acid addition salt, for example, an inorganic acid salt such as hydrochloride, sulfate, phosphate, acetate, maleate, fumarate, tartrate, citrate, lactate, etc. Organic acid salts of
本発明の水中油型乳化組成物にピリドキシン又はその塩を配合する場合、その配合量は、本発明の水中油型乳化組成物に対して、通常0.001〜5質量%、好ましくは0.05〜1質量%である。 When pyridoxine or a salt thereof is blended in the oil-in-water emulsion composition of the present invention, the blending amount is usually 0.001 to 5% by mass, preferably 0.005%, based on the oil-in-water emulsion composition of the present invention. It is 05-1 mass%.
本発明の水中油型乳化組成物は、おむつかぶれの改善効果を向上させる点から、更に殺菌剤を含有することが好ましい。殺菌剤としては、皮膚外用剤に配合できるものであれば特に制限はなく、例えばイソプロピルメチルフェノール、サリチル酸又はその塩、ヒノキチオール、感光素、塩化セチルピリジニウム、塩化ベンザルコニウム、トリクロサン、グアイアズレン、塩酸クロルヘキシジン、好ましくはイソプロピルメチルフェノールが挙げられる。 The oil-in-water emulsion composition of the present invention preferably further contains a bactericidal agent from the viewpoint of improving the effect of improving diaper rash. The bactericidal agent is not particularly limited as long as it can be blended into a skin external preparation. For example, isopropylmethylphenol, salicylic acid or a salt thereof, hinokitiol, photosensitizer, cetylpyridinium chloride, benzalkonium chloride, triclosan, guaiazulene, chlorhexidine hydrochloride Preferably, isopropylmethylphenol is used.
本発明の水中油型乳化組成物に殺菌剤を配合する場合、その配合量は、本発明の水中油型乳化組成物に対して、通常0.001〜1質量%、好ましくは0.05〜0.8質量%である。 When mix | blending a disinfectant with the oil-in-water type emulsion composition of this invention, the compounding quantity is 0.001-1 mass% normally with respect to the oil-in-water type emulsion composition of this invention, Preferably 0.05- 0.8% by mass.
本発明の水中油型乳化組成物の剤形は、粘度が1〜1000mPa・s、特に1〜500mPa・sである製剤であれば特に制限はなく、例えば液剤、懸濁剤、乳剤、エアゾール剤、ローション剤が挙げられる。 The dosage form of the oil-in-water emulsion composition of the present invention is not particularly limited as long as it is a preparation having a viscosity of 1 to 1000 mPa · s, particularly 1 to 500 mPa · s. For example, a liquid agent, a suspension agent, an emulsion, an aerosol agent And lotions.
本発明の水中油型乳化組成物は、ピリドキシン又はその塩を配合する場合には、当該成分の安定性の点から、pHが2〜5になるように調整することが好ましい。 The oil-in-water emulsion composition of the present invention is preferably adjusted to have a pH of 2 to 5 from the viewpoint of the stability of the component when pyridoxine or a salt thereof is blended.
本発明の水中油型乳化組成物は、日常的に行われるおむつ交換時や沐浴時に簡便に適用できる点から、入浴剤又は清拭剤組成物として用いることが好ましい。 The oil-in-water emulsion composition of the present invention is preferably used as a bathing agent or a wiping agent composition from the viewpoint that it can be easily applied during routine diaper changes or bathing.
本発明の水中油型乳化組成物には、前記成分の他に、有機酸及び/又はその塩、非イオン界面活性剤、油性成分を配合することができる。 In addition to the above components, the oil-in-water emulsion composition of the present invention may contain an organic acid and / or a salt thereof, a nonionic surfactant, and an oil component.
前記有機酸としては、例えばグリコール酸、乳酸、リンゴ酸、クエン酸、アスコルビン酸、安息香酸、フマル酸、酒石酸、マロン酸、アジピン酸、ピロリドンカルボン酸、サリチル酸、コハク酸が挙げられ、これらは単独で、又は2種以上の組み合わせで用いられる。有機酸の塩としては、水溶液の塩、例えばナトリウム塩等のアルカリ金属塩が好ましい。 Examples of the organic acid include glycolic acid, lactic acid, malic acid, citric acid, ascorbic acid, benzoic acid, fumaric acid, tartaric acid, malonic acid, adipic acid, pyrrolidone carboxylic acid, salicylic acid, and succinic acid. Or in combination of two or more. As the salt of the organic acid, a salt of an aqueous solution, for example, an alkali metal salt such as a sodium salt is preferable.
前記非イオン界面活性剤としては、例えば、グリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、テトラオレイン酸ポリオキシエチレンソルビット、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリグリセリン脂肪酸エステル等が挙げられる。 Examples of the nonionic surfactant include glycerin fatty acid ester, propylene glycol fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, tetraoleic acid polyoxyethylene sorbitol, polyoxyethylene alkyl ether, polyoxyethylene polyoxy Examples include propylene alkyl ether, polyethylene glycol fatty acid ester, polyoxyethylene hydrogenated castor oil, and polyglycerin fatty acid ester.
前記油性成分としては、例えば、大豆油、コメヌカ油、ホホバ油、アボガド油、アーモンド油、オリーブ油、カカオ脂、ゴマ油、パーシック油、ヒマシ油、ヤシ油、ミンク油、牛脂、豚脂等の天然油脂、これらの天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリド、2−エチルヘキサン酸グリセリド等の合成グリセリド、ジグリセリド等の油脂類;カルナウバロウ、鯨ロウ、ミツロウ、ラノリン等のロウ類;流動パラフィン、ワセリン、パラフィン、マイクロクリスタリンワックス、セレシン、スクワラン、プリスタン等の炭化水素類;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、リノール酸、リノレン酸、ラノリン酸、イソステアリン酸等の高級脂肪酸類;ラウリルアルコール、セチルアルコール、ステアリルアルコール、オレイルアルコール、コレステロール、2−ヘキシルデカノール等の高級アルコール類;オクタン酸セチル、乳酸ミリスチル、乳酸セチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、アジピン酸イソプロピル、ステアリン酸ブチル、オレイン酸デシル、イソステアリン酸コレステロール等のエステル類;精油類;シリコーン油類が挙げられる。 Examples of the oil component include natural fats and oils such as soybean oil, rice bran oil, jojoba oil, avocado oil, almond oil, olive oil, cacao butter, sesame oil, persic oil, castor oil, coconut oil, mink oil, beef tallow and lard. , Hydrogenated hardened oil obtained by hydrogenation of these natural fats and oils and fats such as synthetic glycerides and diglycerides such as myristic acid glyceride and 2-ethylhexanoic acid glyceride; waxes such as carnauba wax, whale wax, beeswax and lanolin; Hydrocarbons such as paraffin, petrolatum, paraffin, microcrystalline wax, ceresin, squalane, pristane; lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, lanolinic acid, isostearic acid Higher fatty acids such as lauryl alcohol, Higher alcohols such as til alcohol, stearyl alcohol, oleyl alcohol, cholesterol, 2-hexyldecanol; cetyl octoate, myristyl lactate, cetyl lactate, isopropyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, Examples include esters such as cholesterol isostearate; essential oils; and silicone oils.
本発明の水中油型乳化組成物には、前記成分の他に、必要に応じて、水溶性高分子、無機顔料、多価アルコール、防腐剤、香料、無機塩類、ビタミン類、蛋白分解酵素、その他の成分を添加することができる。 In the oil-in-water emulsion composition of the present invention, in addition to the above components, if necessary, a water-soluble polymer, an inorganic pigment, a polyhydric alcohol, a preservative, a fragrance, an inorganic salt, a vitamin, a proteolytic enzyme, Other ingredients can be added.
前記水溶性高分子としては、例えば、デキストリン、キサンタンガム等の微生物系多糖類、デンプン、グアーガム、カラギーナン、寒天、マンナン等の植物系多糖類、ゼラチン、カゼイン、アルブミン、コラーゲン等の動物系蛋白質などの天然高分子、また、半合成高分子としては、メチルセルロース、エチルセルロース、カルボキシメチルセルロースナトリウム、ヒドロキシエチルセルロース、カチオン化セルロース等のセルロース系、可溶性デンプン、メチルデンプン等のデンプン系、アルギン酸塩、アルギン酸プロピレングリコールエステル等のアルギン酸系が挙げられる。水溶性合成高分子の例としては、ポリエチレングリコール、ポリビニルアルコール、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリアクリル酸アンモニウム、ポリビニルメチルエーテル等が挙げられる。 Examples of the water-soluble polymer include microbial polysaccharides such as dextrin and xanthan gum, plant polysaccharides such as starch, guar gum, carrageenan, agar and mannan, and animal proteins such as gelatin, casein, albumin and collagen. Natural polymers and semisynthetic polymers include celluloses such as methylcellulose, ethylcellulose, sodium carboxymethylcellulose, hydroxyethylcellulose, and cationized cellulose, starches such as soluble starch and methyl starch, alginates, propylene glycol alginate, etc. Of the alginic acid system. Examples of the water-soluble synthetic polymer include polyethylene glycol, polyvinyl alcohol, carboxyvinyl polymer, sodium polyacrylate, ammonium polyacrylate, polyvinyl methyl ether and the like.
無機顔料としては、例えば酸化チタン、炭酸カルシウム、炭酸マグネシウム、酸化亜鉛(亜鉛華)、タルク、ケイ酸カルシウム、無水ケイ酸、カオリン、ベントナイト、雲母チタン等が挙げられる。 Examples of the inorganic pigment include titanium oxide, calcium carbonate, magnesium carbonate, zinc oxide (zinc white), talc, calcium silicate, anhydrous silicic acid, kaolin, bentonite, and mica titanium.
多価アルコールとしては、例えばエチレングリコール、プロピレングリコール、1,3−ブチレングリコール、3−メチル−1,3−ブタンジオール等の2価アルコール;グリセリン等の3価アルコール;ソルビット、マンニット等の糖類が挙げられる。 Examples of the polyhydric alcohol include dihydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and 3-methyl-1,3-butanediol; trihydric alcohols such as glycerin; saccharides such as sorbit and mannitol. Is mentioned.
防腐剤としては、例えばパラオキシ安息香酸エステル(例えば、メチルパラベン)、安息香酸、安息香酸塩、フェノキシエタノールが挙げられる。香料としては、例えばラベンダー油、ジャスミン油、レモン油、オレンジ油、ローズマリー油等の天然香料、ゲラニオール、シトロネロール、フェネチルアルコール等の合成香料が挙げられる。 Examples of the preservative include paraoxybenzoic acid ester (for example, methylparaben), benzoic acid, benzoate, and phenoxyethanol. Examples of the fragrances include natural fragrances such as lavender oil, jasmine oil, lemon oil, orange oil, and rosemary oil, and synthetic fragrances such as geraniol, citronellol, and phenethyl alcohol.
無機塩類としては、例えば硫酸ナトリウム、硫酸マグネシウム、塩化ナトリウム、塩化カリウム、チオ硫酸ナトリウムが挙げられる。 Examples of inorganic salts include sodium sulfate, magnesium sulfate, sodium chloride, potassium chloride, and sodium thiosulfate.
ビタミン類としては、例えばビタミンA;ピリドキシン又はその塩以外のビタミンB;ビタミンD、ビタミンE、ビタミンF、ビタミンK、ビタミンP、ビタミンU、カルニチン、フェルラ酸、γ−オリザノール、リポ酸、オロット酸及びその誘導体等が挙げられる。蛋白分解酵素としては、例えばペプシン、トリプシン、キモトリプシン、カテプシン、パパイン、ブロメライン、フィシン及び細菌酵母、カビ由来のプロテアーゼ等が挙げられる。 Examples of vitamins include vitamin A; vitamin B other than pyridoxine or its salt; vitamin D, vitamin E, vitamin F, vitamin K, vitamin P, vitamin U, carnitine, ferulic acid, γ-oryzanol, lipoic acid, orotic acid And derivatives thereof. Examples of the proteolytic enzyme include pepsin, trypsin, chymotrypsin, cathepsin, papain, bromelain, ficin, bacterial yeast, and mold-derived protease.
その他の成分としては、イオウ、鉱砂、湯の花、中性白土、卵黄末、イリ糠、雲母末、脱脂粉乳、海藻エキス、色素等が挙げられる。 Examples of other components include sulfur, mineral sand, hot spring flowers, neutral white clay, egg yolk powder, iri cocoon powder, mica powder, skim milk powder, seaweed extract, and pigments.
本発明の水中油型乳化組成物は、N−アシルタウリン塩、及び必要に応じて、ピリドキシン又はその塩、殺菌剤、有機酸及び/又はその塩、非イオン界面活性剤、油性成分、その他の成分を、通常、水と混合して液状とすることにより製造する。 The oil-in-water emulsion composition of the present invention comprises an N-acyl taurine salt and, if necessary, pyridoxine or a salt thereof, a fungicide, an organic acid and / or a salt thereof, a nonionic surfactant, an oil component, The component is usually produced by mixing with water to make it liquid.
以下、実施例により本発明を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。なお、以下に示す配合量(%)は質量基準である。また、以下の実施例及び比較例において、水中油型乳化組成物の粘度の測定、並びに安定性及び浴湯での泡立ちの評価は以下のようにして行った。 EXAMPLES Hereinafter, although an Example demonstrates this invention concretely, this invention is not limited to these Examples. In addition, the compounding quantity (%) shown below is a mass reference | standard. Moreover, in the following examples and comparative examples, the measurement of the viscosity of the oil-in-water emulsion composition and the evaluation of the stability and foaming in bath water were performed as follows.
(1)粘度の測定方法
B型粘度計を用いて、試料温度:20℃、ローター:No.1(200mPa・s未満)又はNo.2(200〜1000mPa・s)、回転速度:30rpm、測定時間:60秒の条件で測定した。
(1) Method for measuring viscosity Using a B-type viscometer, sample temperature: 20 ° C., rotor: No. 1 (less than 200 mPa · s) or No. 1 2 (200 to 1000 mPa · s), rotation speed: 30 rpm, measurement time: 60 seconds.
(2)安定性の評価方法
調製した水中油型乳化組成物を透明な密閉ガラス瓶に入れ、50℃定温のインキュベーターに保存して1ヵ月後の乳化状態を目視により評価した。
(判定基準) ○:変化なし、×:分離
(2) Stability Evaluation Method The prepared oil-in-water emulsion composition was placed in a transparent sealed glass bottle, stored in a 50 ° C. constant temperature incubator, and the emulsified state after one month was visually evaluated.
(Criteria) ○: No change, ×: Separation
(3)浴湯での泡立ちの評価方法
40℃、200Lの浴湯に各々60mLを溶解し、追い焚き時の泡立ちを目視により評価した。
(判定基準) ○:泡立ちなし、△:わずかに泡立つ、×:泡多い
(3) Evaluation method of foaming in bath water 60 mL of each was dissolved in 40 L, 200 L bath water, and foaming at the time of reheating was visually evaluated.
(Criteria) ○: No foaming, Δ: Slightly foaming, ×: Many foams
(実施例1)
表1に示す組成物に表2の陰イオン界面活性剤を各々1.0%配合し、pH4に調整して得た100mPa・s以下の水中油型乳化組成物について、50℃で1ヵ月経過後の安定性を評価した。結果を表2に示す。
Example 1
One month elapsed at 50 ° C. for an oil-in-water emulsion composition of 100 mPa · s or less obtained by adding 1.0% of the anionic surfactant of Table 2 to the composition shown in Table 1 and adjusting to pH 4 Later stability was evaluated. The results are shown in Table 2.
表2に示すとおり、種々の陰イオン界面活性剤の中で、N−アシルタウリン塩であるN−ラウロイル−N−メチルタウリンナトリウム及びN−ステアロイル−N−メチルタウリンナトリウムのみが、水中油型乳化組成物を安定化させることができた。 As shown in Table 2, among various anionic surfactants, only N-acyl taurine salts, N-lauroyl-N-methyl taurine sodium and N-stearoyl-N-methyl taurine sodium, are oil-in-water emulsified. The composition could be stabilized.
(実施例2及び3、比較例1〜3)
表1に示す組成物に表2の陰イオン界面活性剤として用いたN−ラウロイル−N−メチルタウリンナトリウムの配合比を調整し(未配合(比較例1)、0.05%(比較例2)、0.2%(実施例2)、2%(実施例3)、3%(比較例3))、pH4に調整して得た100mPa・s以下の水中油型乳化組成物について、安定性と浴湯での泡立ちを評価した。結果を表3に示す。
(Examples 2 and 3, Comparative Examples 1 to 3)
The composition ratio of N-lauroyl-N-methyltaurine sodium used as an anionic surfactant in Table 2 was adjusted to the composition shown in Table 1 (unblended (Comparative Example 1), 0.05% (Comparative Example 2) ), 0.2% (Example 2), 2% (Example 3), 3% (Comparative Example 3)), and an oil-in-water emulsion composition of 100 mPa · s or less obtained by adjusting to pH 4 is stable. Sex and foaming in bath water were evaluated. The results are shown in Table 3.
表3に示すとおり、N−ラウロイル−N−メチルタウリンナトリウムの配合比が0.2%(実施例2)及び2%(実施例3)の場合に良好な結果が得られ、未配合(比較例1)及び0.05%(比較例2)は製剤の安定性の点で問題があり、3%(比較例3)は浴湯での泡立ちの点で問題があった。 As shown in Table 3, good results were obtained when the blending ratio of N-lauroyl-N-methyltaurine sodium was 0.2% (Example 2) and 2% (Example 3), and no blending (comparison) Examples 1) and 0.05% (Comparative Example 2) had a problem in terms of stability of the preparation, and 3% (Comparative Example 3) had a problem in terms of foaming in bath water.
(実施例4)
実施例2(N−ラウロイル−N−メチルタウリンナトリウムの配合比:0.2%)の水中油型乳化組成物を用い、生後1歳前後の軽度おむつかぶれの乳幼児19名に使用した際の改善効果を評価した。A群(9名)は水中油型乳化組成物を7日間使用し、その後7日間未使用後の皮膚状態を評価した。B群(10名)は未使用期間7日後から水中油型乳化組成物を7日間使用し皮膚状態を評価した。尚、A群とB群の対象者は任意に選定した。水中油型乳化組成物の使用方法は、全ての乳幼児について、おむつ交換時の清拭(水中油型乳化組成物8mLを2Lの水(温水)に溶解し、ガーゼ等に浸しお尻まわりを清拭する)及び沐浴(水中油型乳化組成物8mLに対してお湯20Lの割合に溶解し入浴する)で行った。皮膚評価は、未使用時(7日後)と使用時(7日後)の皮膚状態を皮膚科医による紅斑等の診断、及び保護者による改善度合いのVAS評価により行った。
結果を表4及び5に示す。
Example 4
Improvement when used in 19 infants with mild diaper rash around 1 year old using the oil-in-water emulsion composition of Example 2 (N-lauroyl-N-methyltaurine sodium mixture ratio: 0.2%) The effect was evaluated. Group A (9 persons) used the oil-in-water emulsion composition for 7 days, and then evaluated the skin condition after 7 days of non-use. Group B (10 persons) used the oil-in-water emulsion composition for 7 days from 7 days after the unused period, and evaluated the skin condition. In addition, the subjects of the A group and the B group were arbitrarily selected. The method of using the oil-in-water emulsified composition is to wipe all babies at the time of changing diapers (dissolve 8 mL of the oil-in-water emulsified composition in 2 L of water (warm water), soak it in gauze, etc. Wiping) and bathing (dissolve in a ratio of 20 L of hot water to 8 mL of the oil-in-water emulsion composition and take a bath). Skin evaluation was performed by diagnosing erythema etc. by a dermatologist and VAS evaluation of the degree of improvement by a guardian on the skin condition when not in use (after 7 days) and when in use (after 7 days).
The results are shown in Tables 4 and 5.
表4及び5に示すとおり、ピリドキシン塩酸塩を配合した製剤は、おむつかぶれに効果があった。 As shown in Tables 4 and 5, the preparation containing pyridoxine hydrochloride was effective in diaper rash.
(実施例5)
実施例2(N−ラウロイル−N−メチルタウリンナトリウムの配合比:0.2%)の処方について、クエン酸とクエン酸ナトリウムの配合比を加減して、表6に示すとおりに製剤pHを調整した。各々のサンプルを50℃に保管し、3ヵ月経過後に液体クロマトグラフィーにてピリドキシン塩酸塩の残存率を測定した。結果を表6に示す。
(Example 5)
For the formulation of Example 2 (N-lauroyl-N-methyltaurine sodium mixture ratio: 0.2%), the formulation pH was adjusted as shown in Table 6 by adjusting the mixture ratio of citric acid and sodium citrate. did. Each sample was stored at 50 ° C., and after 3 months, the residual rate of pyridoxine hydrochloride was measured by liquid chromatography. The results are shown in Table 6.
表6に示すとおり、ピリドキシンはpH3.1〜4.6の間で優れた安定性を示した。 As shown in Table 6, pyridoxine showed excellent stability between pH 3.1 and 4.6.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009014513A JP5427422B2 (en) | 2009-01-26 | 2009-01-26 | Oil-in-water emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009014513A JP5427422B2 (en) | 2009-01-26 | 2009-01-26 | Oil-in-water emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010168334A JP2010168334A (en) | 2010-08-05 |
JP5427422B2 true JP5427422B2 (en) | 2014-02-26 |
Family
ID=42700821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009014513A Active JP5427422B2 (en) | 2009-01-26 | 2009-01-26 | Oil-in-water emulsion composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5427422B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6817001B2 (en) * | 2016-09-14 | 2021-01-20 | 花王株式会社 | Oil-in-water liquid bath salt |
JP7359436B2 (en) * | 2019-12-06 | 2023-10-11 | 株式会社ダリヤ | bath salt composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11228380A (en) * | 1998-02-20 | 1999-08-24 | Shiseido Co Ltd | Cosmetic for improving chapped skin |
CN100352414C (en) * | 2002-03-29 | 2007-12-05 | 株式会社高丝 | Cosmetic preparation |
WO2005092388A1 (en) * | 2004-03-26 | 2005-10-06 | Terumo Kabushiki Kaisha | Liposome preparation |
JP2005343943A (en) * | 2004-06-01 | 2005-12-15 | Shiseido Co Ltd | Oil-in-water type detergent composition and sheet-like detergent |
JP5437552B2 (en) * | 2006-03-30 | 2014-03-12 | 株式会社コーセー | Two-component mixed topical skin preparation |
-
2009
- 2009-01-26 JP JP2009014513A patent/JP5427422B2/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11911498B2 (en) | 2020-06-01 | 2024-02-27 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Also Published As
Publication number | Publication date |
---|---|
JP2010168334A (en) | 2010-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5427422B2 (en) | Oil-in-water emulsion composition | |
JP6118546B2 (en) | Oil-in-water emulsion composition | |
JP5695388B2 (en) | Oil-in-water emulsion composition | |
JP4406498B2 (en) | Skin cosmetics | |
JP2008044866A (en) | Cream composition | |
JP5383223B2 (en) | Diaper rash remedy | |
JP2014047158A (en) | Water-in-oil emulsified composition and production method thereof | |
JP2000247893A (en) | Antimicrobial agent, bathing agent composition and skin cleansing agent composition | |
JP2019218291A (en) | Creamy external composition and production method thereof | |
JP2006056851A (en) | Cosmetic | |
WO2014128922A1 (en) | Viscous detergent composition | |
JP5495709B2 (en) | Skin cleanser composition | |
JP6081097B2 (en) | Oil-in-water emulsion composition | |
JP5923302B2 (en) | Oil-in-water emulsion composition | |
JP2005325186A (en) | Cleanser composition | |
JP2005325246A (en) | Cleanser composition | |
JPH11106325A (en) | Skin lotion | |
JP4499929B2 (en) | Liquid bath composition | |
JP2004277364A (en) | Foam cleansing preparation for sensitive skin | |
JP2005053867A (en) | Dandruff-suppressing composition | |
JP5901268B2 (en) | Cleaning composition | |
KR20240076768A (en) | Liquid external skin composition | |
JPH09263510A (en) | Emulsified composition | |
JP2024049678A (en) | Oil-based cleansing cosmetics | |
JPH07228519A (en) | Bathing agent for jet bath |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120125 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130124 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130708 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131105 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131202 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5427422 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |